Optical Dialysis Adequacy Monitoring: Small Uremic Toxins and Contribution to UV-Absorbance Studied by HPLC by Kai Lauri et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Optical Dialysis Adequacy Monitoring:  
Small Uremic Toxins and Contribution to  
UV-Absorbance Studied by HPLC  
Kai Lauri1, Jürgen Arund1, Jana Holmar1, Risto Tanner1,2,  
Merike Luman3 and Ivo Fridolin1  
1Department of Biomedical Engineering, Technomedicum, Tallinn University of Technology,  
2Laboratory of Chemical Physics, National Institute of Chemical Physics and Biophysics, 
3Department of Dialysis and Nephrology, North Estonia Medical Centre,  
Estonia 
1. Introduction  
Uremic toxicity is described as a clinical picture resulting from impaired renal elimination 
and accumulation of uremic toxins in the body. Uremic toxins can be classified as small 
water-soluble compounds, middle molecules and protein-bound compounds. A long list of 
possible uremic toxins has been identified in recent decades. Under normal conditions these 
compounds are excreted by healthy kidneys. If kidney function fails, waste products 
accumulate in the blood and in the body. Dialysis treatment replaces some kidney functions 
through diffusion (waste removal) and ultrafiltration of fluid across a semi-permeable 
membrane, which is a thin layer of material with holes or pores of various sizes. A deeper 
understanding about the accumulation and removal mechanisms of the retained solutes 
during care of renal insufficiency is needed (Eloot, 2008; Eloot, 2007). This understanding 
would be especially informative with respect to predicting the mode of action of uremic 
toxins and their specific role in complications associated with dialysis or ureamia, but also 
with cardiovascular disease and inflammation (Vanholder, et al., 2008; Vanholder, 2003). 
The methods contributing to the identification, characterisation and evaluation of uremic 
retention solutes could be assessed in order to ensure dialysis adequacy and quality 
(Vanholder, 2005). The choice of the correct concentration of potential uremic toxins is still 
an unresolved issue (Vanholder, 2003). In everyday clinical practice, uremic components are 
not examined due to the measurement of most uremic components using the available 
laboratory methods being difficult and complex. A number of standard biochemical 
techniques are used in clinical laboratories, but there is no universal methodology. In 
addition, some chromatographic methods have been developed which explore uremic 
retention solutes.  
Dialysis efficiency and quality has been an important issue accompanied by optimisation 
and the best outcome of the treatment of chronic end stage renal disease for many years. In 
connection to this, online monitoring of the dialysis dose has been suggested as an effective 
way of improving treatment quality. The concept of online monitoring is based on the real-
time measurement of chemical signals coming from the patient. This enables the early 
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recognition of signs of intolerance and allows for early intervention. Despite the first online 
monitors of dialysis doses being available today, it is essential to monitor the patient’s 
condition during the dialysis session and, if necessary, change some conditions of dialysis 
treatment (e.g. time) more specifically considering uremic toxins with various characteristics 
and elimination profiles.  
The aim of this chapter is to describe and assess performance of optical dialysis adequacy 
monitoring technique related to the removal of uremic retention solutes during dialysis. The 
assessment is based on the high performance liquid chromatography (HPLC) profiles of the 
serum and the spent dialysate connected to the origin of the cumulative and integrated UV 
absorbance arising from the contribution of uremic retention solutes - chromophores, among 
them probably several uremic toxins. 
2. Dialysis adequacy and online monitoring 
Dialysis adequacy means providing a sufficient amount of dialysis treatment to maintain a 
uremic patient in the best condition. The goal of qualitatively treated dialysis is to prevent 
complications due to uremic toxicity. 
Some recent studies are reviewed suggesting that uremic toxins are involved in the 
progression of renal failure and are at least partially removed by hemodialysis (Lesaffer, 
2000; Eloot, 2008; Vanholder, 2003). The efficiency of a dialysis session has been estimated 
through concentration of uremic toxins measured before and after the dialysis session. A 
classic marker of the dialysis dose and adequacy is a small molecule urea.  
Two methods are generally used to assess dialysis adequacy: URR and Kt/V. The urea 
reduction ratio (URR) is based on tests of blood urea, by measuring the levels before and 
after treatment to show how much has been removed. The Kt/V is mathematically related to 
the URR and can be derived from it (NKF-DOQI, 2006). In a simplified model of urea 
removal from a fixed volume with no urea generation, Kt/V is related to URR as follows: 
 Kt/V = -ln (1 – URR) (1) 
In general, this method of dialysis adequacy is based on pre- and post-dialysis 
measurements of urea concentration. Online methods are considered to be more accurate 
than methods based on pre- and post-dialysis urea concentrations and have been found to 
be better suited to clinical routines. Online monitoring of the dialysis dose has been 
suggested as a valuable tool in ensuring adequate dialysis prescription (Locatelli, 2005).  
3. Optical dialysis online monitoring 
Two optical techniques have made progress toward clinical use over the past ten years – 
namely the ultraviolet (UV) absorbance and near infrared (NIR) techniques. The 
experimental results indicate very good correlation between UV absorbance and several 
small solutes such as urea, creatinine and uric acid in the spent dialysate and in the blood 
for every individual treatment at a fixed wavelength of 285 nm (Fridolin, 2002). Good 
correlation between UV absorbance and a small removed waste solute such as urea enables 
the determination of Kt/V for urea (Fridolin, 2003). The NIR method can measure urea 
directly using signal processing of the raw NIR spectra (Cho, 2008; Eddy, 2001; Eddy, 2003).   
To implement NIR technology as a simple and robust sensor based on Fourier transform 
near-infrared (FT-NIR) spectrometer or acousto optical tunable filter (AOFT) based 
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spectrometer is far more complicated because of the underlying optical principle, in which 
interference or diffraction is utilised (Jensen, 2002; Cho, 2008). The UV method is more 
straightforward and is not as demanding considering the source and detector characteristics 
and other technological modules. The UV method has recently been commercialised as a 
monitoring tool for dialysis dose in terms of the urea-based parameters, Kt/V and URR. 
Validation studies of the system have shown that the results with UV technology are 
indistinguishable from blood based Kt/V (Castellarnau, 2010). 
An optical dialysis online monitoring system utilising UV absorbance has been developed 
for the continuous monitoring of the toxins eliminated by the spent dialysate. This system 
represents a spectrophotometer connected to the fluid outlet of the dialysis machine. All 
spent dialysate passes through a specially designed optical cuvette. The transmitted light 
intensity of the spent dialysate is measured. All substances – chromophores – absorbing the 
UV-radiation at a particular wavelength, give the total online UV absorbance curve. The 
schematic clinical set-up of online monitoring experiments is shown in Figure 1.  
 
 
Fig. 1. Clinical experimental set-up and sample analysis 
The obtained UV absorbance values are processed and presented on the computer screen by 
a PC incorporated in the spectrophotometer using special software. The absorbance A of a 
solution, obtained by the spectrophotometer using the pure dialysate as the reference 
solution, is determined as: 





  (2) 
where Ir is the intensity of transmitted light through the reference solution (pure dialysate) 
and Ir+s is the summated intensity of transmitted light through the reference solution 
containing the solutions under study (pure dialysate + waste products from the blood). The 
absorbance is measured in arbitrary units (a.u.). A sampling frequency at two samples per 
minute is usually sufficient, but can be much higher (e.g. if a more detailed curve is desired 
or noise reduction is necessary). 
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The examples of two online signals measured at 280 nm from two different dialysis treatments 
are shown in Figure 2. The UV absorbance is higher at the beginning of treatment because of 
the high concentration of metabolic waste products in the body fluids. When the waste 
products are removed from the blood the UV absorbance decreases during the dialysis session. 
The times at which the blood and dialysate samples were collected are also shown in this 
figure. Blood samples were drawn before the start of dialysis treatment (Bstart) and 
immediately after the treatment (Bend). Dialysate samples were taken 10 minutes after the start 
of the dialysis session (Dstart) and at the end of the treatment (Dend) (210 or 240 minutes). 
 
 
Fig. 2. Example of two different online UV absorbance measurements (at 280 nm). Time 
points when the samples were taken for later analysis are as follows: Dstart - dialysate sample 
collected 10 minutes after start of hemodialysis, Dend- dialysate sample collected at the end 
of hemodialysis, Bstart – blood sample collected before dialysis session, Bend – blood sample 
collected at the end of hemodialysis 
This figure presents a classic picture of UV absorbance signals obtained by the optical online 
dialysis dose monitor, which can be used for estimation of uremic solutes removal.  
As seen from Figure 2, the UV absorbance curves are somewhat different. The exponential 
decrease of the UV absorbance curve represents the elimination rate of the all UV-absorbing 
compounds – chromophores – which varies from patient to patient and from treatment to 
treatment. Good correlation between the UV absorbance measured in the spent dialysate and 
the concentration of several uremic retention solutes, both in the spent dialysate and in the 
blood of the dialysis patients, has been previously shown (Fridolin, 2002). For these reasons 
the origin of the cumulative and integrated UV absorbance arising from the contribution of 
uremic retention solutes, among them probably several uremic toxins, should be investigated.  
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4. HPLC as an analysis tool for biological samples 
High performance liquid chromatography (HPLC) is a technique of analytical chemistry 
which can separate and identify the components of a mixture of different chemical 
compounds in liquid solution. The reversed-phase HPLC technique is the most commonly 
used form of HPLC. This method is recommended as a sensitive, accurate and reproducible 
tool for qualitative and quantitative analysis of aqueous samples (Vanholder, 2001). 
Furthermore, the use of ambient temperature in reversed-phase columns makes it possible 
to investigate the many non-volatile or thermally unstable compounds commonly found in 
biological samples. The principle involved in HPLC testing enables the separation of 
compounds in a mixture more efficiently and faster than that of traditional column 
chromatography.  
In general, the HPLC system consists of two essential components – a stationary phase and a 
mobile phase. The stationary phase is a column packed with small solid sorbent particles 
and where the separation of different compounds takes place. The mobile phase is a flowing 
liquid (solvent) that transports the compounds from the sample through the stationary 
phase. Thus, the compounds of the mixture travel at different rates due to their relative 
affinities with the solvent and stationary phase. Separation of compounds in the stationary 
phase occurs with slight differences in chemical properties, such as chemical polarity and 
size of non-polar groups. 
Figure 3 is a simple block diagram illustrating the main components of a modern HPLC. A 
system consists of several units: pumping, sample-injection, separation (column), detection 
and data-processing.   
 
 
Fig. 3. Schematic reversed-phase HPLC method principle 
The results of chromatographic analysis are known as chromatograms, where the signal 
intensity from the detector is recorded on the time axis. For HPLC there are several different 
detection methods; the most popular are optical. An ultraviolet-visual light (UV-VIS) 
absorption detector is the main optical detection method. This detector is effective in the 
detection of components with an absorption wavelength of 400 nm or less in the ultraviolet 
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region. There are three types of UV-VIS detectors: a fixed wavelength detector; a variable 
wavelength detector; and a diode array detector (DAD). However, in modern HPLC 
systems DAD is commonly used, which in addition to the UV-VIS signal offers the ability to 
produce an absorption spectrum for every time slice during the chromatogram. A DAD 
detects the absorption in the UV to VIS region. Using the DAD, absorption on a large 
number of wavelengths can be measured simultaneously. This enables us to select the best 
wavelengths for actual analysis. Additionally, one of the advantages of DAD is that it allows 
us to detect sufficiently pure peaks. Often the peak shape itself does not reveal that it 
actually corresponds to two or even more components. In such a case, absorbance rationing 
on several wavelengths is particularly helpful in deciding whether the peak represents a 
single compound or a composite peak. However, compared with a UV-VIS detector, the 
DAD is susceptible to changes, such as lamp fluctuations, and noise is large because the 
amount of light is small.   
For those compounds which fluoresce or which exhibit an appropriate fluorescence due to 
derivatisation, a fluorescence detector is the most sensitive of the existing modern HPLC 
detectors. Its sensitivity is 10-1000 times higher than that of the UV detector for strong UV-
absorbing materials. Fluorescence detectors are very specific and selective compared to 
other optical detectors. A universal detector, but the least sensitive for non-ionic compound 
monitoring, is the refractive index detector. To estimate oxidisable and reducible 
compounds, the most suitable is the electrochemical detector. 
Reversed-phase HPLC has been found to be useful in the analysis of uremic biofluids. A 
number of authors have reported the application of the HPLC method in the analysis of 
dialysate and serum samples already in several decades ago (Schoots, 1989; Schoots, 1982). 
Different detectors have been used. Some naturally fluorescent compounds have been 
separated and identified with a fluorescence detector, in both serum and haemodialysate 
(Niwa, 1993; Barnett, 1985; Swan, 1983). A liquid chromatographic method including a UV 
detector for detection of UV-absorbing solutes in uremic serum has been developed 
(Schoots, 1985; Senftleber, 1976; Knudson 1978). A fixed wavelength at 254 nm was mainly 
used in these studies. Additionally, several types of chromatographic methods, such as gas 
chromatography mass spectrometry (GC-MS), for the detection of uremic toxins has also 
been developed (Niwa, 1997; Niwa, 2009). Mass spectrometry (MS) has been applied to the 
identification and quantification of uremic toxins and uremia-associated modified proteins 
(Niwa, 2009). However, GC-MS cannot analyse highly polar, thermally labile and high-
molecular weight compounds and usually requires sample preparation, such as extraction 
or derivation to make non-volatile compounds thermally stable and volatile.  Compared 
with GC-MS, liquid chromatography mass spectrometry (LC-MS) can separate and identify 
highly polar, thermally labile or high-molecular weight mixture compounds and does not 
require derivation; sample preparation is also simple. Newly developed LC-MS techniques 
have been successfully applied to uremic toxin research with the discovery of novel uremic 
toxins that range from low-molecular weight solutes to small-molecule proteins (Niwa, 
2011). This new analytical method is available today, opening up new horizons for uremic 
toxin identification detected earlier as unidentified HPLC peaks. 
5. HPLC study of UV absorbance profiles 
In order to explain the origin and potential of the online UV absorbance dialysis dose 
monitoring method, the HPLC method of analysing UV absorbance profiles was developed.  
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Ten uremic patients – three females and seven males (mean age 62.6 ± 18.6 years) – 
participated in the study. All of the patients were investigated over a course of 30 
hemodialysis treatments. Three different polysulphone dialysers were used (Fresenius 
Medical Care, Germany): a low flux membrane dialyser F8 HPS (N=14), a low flux 
membrane dialyser F10 HPS (N=3) and a high flux membrane dialyser FX 80 (N=11). The 
elimination of toxins by the different types of semi-permeable membranes was also 
estimated. 
Blood samples were drawn before the start of dialysis treatment (Bstart) and immediately 
after the treatment (Bend) (Figure 2) using the slow flow/stop pump sampling technique. 
Blood was sampled into BD Vacutainer® Glass Serum Tube (red cup, Beckton Dickinson) 
and was allowed to clot. After centrifugation at 3000 r.p.m. the serum was ready for clinical 
chemistry analysis. Small molecules – creatinine (MW=113.12 Da), uric acid (MW=168.11 
Da) and urea (MW=60.06 Da) – were measured at the Clinical Chemistry Laboratory of the 
North Estonia Medical Centre using standardised methods (Hitachi 912 autoanalyser, 
Roche, Switzerland). The accuracy for creatinine was 5%, for uric acid 2% and for urea 4%. 
For HPLC analysis the additional pre-treatment of the centrifugated serum was necessary to 
release the blood proteins. The serum samples were purified from proteins by centrifuging 
with two different Microcon centrifugal filters (Millipore, USA): a YM-3 with cut-off 3 kDa 
and a YM-100 with cut-off 70 kDa. The aim of using different filters was to estimate the 
presence of different-sized molecules in the serum.  
Dialysate samples were taken 10 minutes after the start of the dialysis session (Dstart) and 
immediately after the treatment (Dend) (210 or 240 minutes) (Figure 2). Also, pure dialysate, 
used as the reference solution, was collected before each dialysis session, when the dialysis 
machine was being prepared and the conductivity was stable. For HPLC analysis, the 
dialysate samples were acidified with formic acid to pH 4.0. Sample sizes of 50 μL or 100 μL 
were used for chromatographic separation. Figure 4 presents a block diagram illustrating 
the collection and handling of blood and dialysate samples.  
 
 
Fig. 4. Block diagram of blood and dialysate sample collection and handling 
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The HPLC instrumentation and tools were as follows: a diode array spectrophotometric 
detector (DAD, Perkin Elmer, USA); a manual injector (Rheodyne, USA); and a Zorbax C8 4.6 
x 250 mm column (Du Pont Instruments, USA) with security guard KJO-4282 (Phenomenex, 
USA). The eluent was mixed with 0.05 M formic acid (pH 4.0), HPLC grade methanol and 
HPLC-S grade acetonitrile (Rathburn, Scotland), with a six-step gradient programme. The total 
flow rate of 1 mL/min was used continuously and the column temperature was adjusted to 
30ºC. The method followed has been described previously (Lauri, 2010). The chromatographic 
peaks were detected by the UV detector at wavelengths of 254 and 280 nm. The data was 
processed by means of Turbochrom WS and Turboscan 200 software from Perkin Elmer.  
The decrease of the uremic retention solutes was estimated as the reduction ratio (RR) and 
assessed as a percentage (%). Thus, the RR of compounds was defined as a function of pre-








  (3) 
5.1 Results 
The results from the studies obtained by the HPLC method in order to analyse the UV 
absorbance profiles of the serum and dialysate samples are presented below. The results are 
presented as mean ± standard deviation (SD). A student’s t-test was used to compare groups 
of values wherein p < 0.05 was considered significant. Pearson’s correlation coefficient (r) 
between the UV absorbance from HPLC and online monitoring versus concentration of the 
substances in the blood was investigated. Samples taken at times coinciding with the self-
tests or alarms of the dialysis machine were excluded (3 of 60 dialysate samples). Some 
sessions were excluded due to the technical failure of the spectrophotometer (3 of 30 
sessions) and due to laboratory errors (3 of 30 sessions). The data analyses were performed 
in Microsoft Excel 2003 (for Windows). 
The characteristic HPLC profiles of the spent dialysate at the start of the dialysis session 
(Dstart) and at the end (Dend) are presented in Figure 5. When comparing the start and end 
values, the decrease in the height of the peaks (due to solute removal from the blood and 
into dialysate during dialysis) can be clearly seen.  
As can be seen from this figure, a number of higher prevalent peaks can be observed from 
the HPLC profiles indicating the presence of chromophores, which are the main cause of 
cumulative and integrated UV absorbance. The highest peak on the HPLC profile is detected 
as uric acid causing a substantial amount of UV absorbance. 
Figure 6 shows the HPLC chromatograms of the serum (filter YM-3 with cut-off 3 kDa) 
measured on wavelengths of 254 nm and 280 nm. Identified HPLC peaks, such as creatinine, 
uric acid (the highest contribution), hypoxanthine, indoxyl sulphate and hippuric acid, are 
shown. Absorbing spectra of two unknown persistent peaks (P1 and P2) were identified at 
retention times (RT) of 15.46 and 15.82 min.  
Some chromophores, such as P2, creatinine, hypoxanthine and hippuric acid, give higher 
peaks on a wavelength of 254 nm, while P1 and indoxyl sulphate are better identified on a 
wavelength of 280 nm. This is due to the absorbing spectrum characteristics of the UV 
chromophores. This confirms the results obtained by the spectrophotometric analysis in this 
UV region.  
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Fig. 5. Characteristic HPLC profiles of spent dialysate monitored on a wavelength of 280 
nm; Dstart - dialysate sample collected 10 minutes after start of hemodialysis, Dend - dialysate 
sample collected at the end of hemodialysis  
 
Fig. 6. Characteristic HPLC profiles of serum monitored on different wavelengths. Blood 
samples were collected before the dialysis session (Bstart ) and monitored on wavelengths of 
254 nm and 280 nm. Detected HPLC peaks – uremic toxins – are presented. 
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As seen from Figure 6, around ten peaks on the HPLC profiles can be selected forming the 
major part of the total HPLC signal. As a result of this, the total area of the ten main peaks 
(Top 10 area %) was estimated. The comparison for Top 10 area % in the serum and 
dialysate is presented in Figure 7. The contribution of ten main peaks forms approximately 
80-90% of all HPLC peaks in both spent dialysate and serum. However, there is a difference 
in the number of peaks on different wavelengths. In comparison with the 254 nm 
wavelength, the Top 10 area % on the 280 nm wavelength is higher. According to the HPLC 
profiles obtained (Figure 5 and 6), the largest contribution to Top 10 area % on the 280 nm 
wavelength originates from the small water-soluble non-protein-bound uremic toxin uric 
acid. Additionally, there was no significant difference between the serum results filtered 
with different type of filter cut-off (3 kDa and 70 kDa) (p< 0.05). 
 
 
Fig. 7. Comparison of Top 10 area % on wavelengths of 254 nm and 280 nm in serum (filter 
YM-3 with cut-off 3 kDa) and spent dialysate 
The RR of the detected chromatographic solutes was estimated. Table 1 presents the 
comparison of the RR (%) of solutes and all HPLC UV absorbance peaks on wavelengths of 
254 nm and 280 nm in serum and for the online UV absorbance at 280 nm in the spent 
dialysate for different types of membranes: low flux (F8 HPS, F10 HPS) and high flux 
(FX80). There was no significant difference between the results for RR of low flux and high 
flux membranes (p < 0.05).  
Hippuric acid had the highest RR, while the small water-soluble compound hypoxanthine 
and protein-bound solute indoxyl sulphate had the lowest RR. The RR of all HPLC Ppeaks 
at 280 nm was similar to uric acid and urea and higher than the RR of online UV absorbance 
at 280 nm and creatinine. At the same time, the RR of all HPLC peaks at 254 nm and P2 were 
lower than uric acid and urea. Online UV absorbance at 280 nm, creatinine and P2 were all 
removed in a statistically similar way (p < 0.05) and had lower RR than uric acid, urea and 
all HPLC peaks at 280 nm. 
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RR (%) 
Low flux High flux 
Hippuric acid 75.1 ± 11.5 (N=15) 68.1 ± 9.4 (N=10) 
Uric acid 67.7 ± 8.5 (N=15) 65.6 ± 6.7 (N=15) 
Urea 67.0 ± 8.7 (N=15) 63.2 ± 5.07 (N=15) 
All HPLC peaks, 280 nm 65.2 ± 9.6 (N=15) 60.6 ± 7.9 (N=14) 
P1 62.1 ± 13.0 (N=12) 61.0 ± 5.3 (N=7) 
All HPLC peaks, 254 nm 60.2 ± 12.5 (N=14) 57.2 ± 7.7 (N=13) 
P2 59.2 ± 17.5 (N=13) 51.6 ± 5.9 (N=12) 
Online UV absorbance,  280 nm 58.1 ± 8.3 (N=15) 57.0 ± 10.4 (N=13) 
Creatinine 58.2 ± 7.7 (N=15) 56.6 ± 5.4 (N=15) 
Hypoxanthine 42.6 ± 16.0 (N=10) 46.1 ± 18.5 (N=8) 
Indoxyl sulphate 42.1 ± 18.0 (N=13) 47.8 ± 14.0 (N=12) 
Table 1. RR (%) of solutes and total area of all HPLC UV absorbance peaks on wavelengths 
of 254 nm and 280 nm in serum and RR of online UV absorbance at 280 nm in spent 
dialysate for different types of membranes 
As the low flux and high flux membranes showed similar RR for every uremic solute, the 
results can be combined. Figure 8 present an illustrative comparison between the RR of 
serum uric acid, urea and creatinine measured in the clinical laboratory using standardised 
methods, all HPLC peaks measured on two different wavelengths (254 and 280 nm) and 
dialysate online UV absorbance measurement (280 nm).  
 
 
Fig. 8. Comparison of RR of small molecular uremic retention solutes (uric acid, urea and 
creatinine) in serum, RR of all HPLC serum peaks on two different wavelengths (254 and 
280 nm) and spent dialysate online UV absorbance (280 nm) 
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The RR of urea and uric acid and the RR of all HPLC peaks at 280 nm are > 60%, while the 
RR of all HPLC peaks at 254 nm, of online UV absorbance measurement and creatinine are < 
60%. Interestingly, the removal of urea and uric acid was statistically undifferentiated (p > 
0.05). Figure 8 shows that the RR of serum creatinine is statistically different (p < 0.05) from 
the RR of serum urea and uric acid concentrations and from the RR of all HPLC peaks in the 
serum (at 280 nm), but not different from that of 254 nm. The RR of online measurement is 
comparable with the RR of creatinine and of all HPLC peaks at 254 nm and lower than the 
RR of urea, uric acid and all HPLC peaks at 280 nm (p < 0.05). At the same time, the RR of 
serum urea and uric acid are not statistically different; neither are they different from the RR 
of all HPLC peaks at 254 nm and 280 nm (p < 0.05). 
The correlation coefficients between RR UV absorbance at 254 nm and at 280 nm from the 
total area of the HPLC peaks, from online monitoring at 280 nm and RR for certain 
substances with different molecular weights in spent dialysate and serum are shown in 
Table 2.  
  
 Uric acid Urea Creatinine 
RR of all HPLC peaks, 254 nm 0.755 0.811 0.812 
RR of all HPLC peaks, 280 nm 0.933 0.881 0.926 
Online UV absorbance, 280 nm 0.890 0.873 0.888 
Table 2. Pearson correlation coefficients between RR of all HPLC peaks (254 nm and 280 
nm), online absorbance at 280 nm and RR of uric acid, urea and creatinine in serum. The 
significance level of the results is P<0.01. 
A high correlation for uric acid, urea and creatinine was obtained in both spent dialysate 
and serum. Some differences regarding 254 nm and 280 nm can be observed. However, urea 
does not represent as good a correlation as uric acid. 
6. Discussion 
From the investigations presented in this chapter we can conclude the following: (i) UV 
absorbance decreases during the dialysis session as the waste products are removed; (ii) a 
number of higher prevalent peaks can be detected in the HPLC profiles; (iii) some low-
molecular-weight uremic solutes were identified from the HPLC profiles contributing to UV 
absorbance, and the main solute responsible for the UV absorbance is uric acid; (iv) a 
difference between HPLC profiles on wavelengths of 254 and 280 nm was found; (v) a higher 
number of detected HPLC peaks in the serum comparing to spent dialysate has been detected; 
(vi) the low flux and high flux membranes showed similar RR for all studied uremic solutes; 
and (vii) the classic dialysis adequacy marker urea and the uremic solute uric acid have good 
correlation with uremic retention solute elimination forming the UV absorbance curve. 
Figures 2 and 5 show how the concentration of the uremic retention solutes – chromophores 
– decreases during a dialysis session in spent dialysate. UV absorbance as well as the height 
of the HPLC peaks are higher at the beginning of the treatment because of the high 
concentration of metabolic waste products in the body fluids and UV absorbance is lower at 
the end of the dialysis session. This demonstrates the possibility of following a single 
dialysis session continuously and to monitor deviations during treatment using a UV 
absorbance online monitor. This enables us to estimate the dialysis efficiency and adjust the 
treatment settings if needed.  
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A number of higher prevalent HPLC peaks representing chromophores can be observed 
(Figure 5 and 6). This indicates that there is a group of compounds, among them several 
uremic toxins, which are the main cause of cumulative and integrated UV absorbance. The 
10 main peaks formed app. 80-90% of the total area of all HPLC peaks; some of these are 
small molecular weight uremic toxins such as uric acid, creatinine, hippuric acid and 
indoxyl sulphate. The variations in the number of HPLC peaks depending on hemodialysis 
treatments and patients have been demonstrated in earlier studies (Schoots, 1982; 
Vanholder, 1992). The difference between two dialysis sessions may arise as shown in 
Figure 2, because of the different composition and removal of the uremic retention solutes 
contained in spent dialysate. When comparing the HPLC profiles of the spent dialysate in 
Figure 5 and those of the serum in Figure 6, more peaks are detected in the serum. Thus, not 
all solutes in serum are transported to dialysate and removed through the semi-permeable 
membrane. 
The number of detected HPLC peaks at 254 nm and 280 nm is also demonstrated in Figure 6 
and 7. The difference in the number of detected HPLC peaks on the wavelengths of 254 nm 
and 280 nm arises due to the characteristic absorbing spectra of the UV chromophores. The 
absorption of many components is higher on the wavelength of 254 nm than 280 nm. This 
confirms the results obtained via the spectrophotometric analysis in this UV region 
(Fridolin, 2003). However, the studies of relations between UV and small water soluble 
molecules such as urea and uric acid indicated that the wavelength of 280 nm may be 
preferred for online measurements when small water soluble molecules should be 
estimated. On this wavelength a relatively strong linear relationship exists between UV 
absorbance and concentrations of urea, creatinine and uric acid (Fridolin, 2002; Uhlin, 2003). 
While the contribution of uric acid forms a considerable part of the total area of HPLC 
peaks, uric acid plays an important role in online UV absorbance dialysis dose monitoring. 
Interestingly, the removal of urea and uric acid was statistically undifferentiated (p > 0.05). 
This information gives us alternative possibilities to use other components and methods to 
monitor urea reduction (URR) in a single hemodialysis session. 
Additionally, the low flux and high flux membranes showed no different removal of the 
studied small molecule uremic toxins as presented in earlier studies (Lesaffer, 2000). In this 
study it was found that the cellulose triacetate and polysulphone HF membranes removed 
similarly classical markers and protein-bound liphophilic solutes as an LF polysulphone 
membrane. Parallel results were obtained even with the concentrations corrected using a 
correction factor based on the total protein concentration at the start and at the end of 
dialysis as used by Lesaffer et al. (Lesaffer, 2000). Furthermore, there was no statistical 
difference between intradialytic start-end values, and removal efficiency for the LF and HF 
membranes estimated by the total area of HPLC peaks at 254 nm and 280 nm in the serum 
and online UV absorbance at 280 nm in the spent dialysate. This indicates that UV 
absorbance follows the behaviour of UV-absorbing compounds – uremic toxins – which are 
the origin of total UV absorbance in serum and spent dialysate. 
The RR values of different identified compounds, the total area of all HPLC UV absorbance 
peaks on the wavelengths of 254 nm and 280 nm in the serum and the RR of online UV 
absorbance at 280 nm in spent dialysate are presented in Table 1 and Figure 8. Taking into 
account the removal efficiency, a difference can be observed in the relation of UV 
absorbance to small water-soluble non-protein-bound solutes and to small protein-bound 
solutes such as indoxyl sulphate. The small non-protein-bound solutes uric acid and urea 
showed a far more substantial decrease of concentration than creatinine being statistically 
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different (p < 0.05) from the RR of serum uric acid and urea. The similar removal of urea and 
uric acid makes it possible to use other components and methods to monitor urea reduction 
during a single hemodialysis session. At the same time, the RR of creatinine is statistically 
different (p < 0.05) from the RR of all HPLC peaks in the serum at 280 nm, but not different 
from that of 254 nm. The RR for online UV absorbance is lower compared to urea. 
Considering that RR (URR) is correlated to Kt/V (NKF-DOQI, 2006), this tendency is 
reported earlier, as the dialysis dose estimated by online UV absorbance was lower than 
Kt/V urea (Uhlin, 2003). The difference between the RR of all HPLC peaks in serum and 
online UV absorbance measurement (at 280 nm) in spent dialysate could be due to different 
chromophores in the serum and spent dialysate and because the serum was collected before 
and the dialysate sample 10 minutes after the start of dialysis. Moreover, the different 
binding of individual uremic retention solutes to serum proteins may modify percentage 
concentration changes of individual solutes in the course of haemodialytic treatment 
(Vanholder, 1992), supported by observations of decreased drug/protein interactions in 
uremic serum (De Smet, 1999).  
The correlation analysis also provides additional insights into the removal characteristics of 
solutes and UV absorbance monitoring (Table 2). The RR of uric acid has the highest 
correlation for RR at 280 nm in both serum and spent dialysate, but not at 254 nm in serum. 
The explanation is the highest contribution of uric acid to UV absorbance compared to other 
chromophores at 280 nm (Figures 5 and 6). However, there are several other strong 
contributions from other compounds beside uric acid at 254 nm, and therefore the 
correlation is lower. The outcome in Table 2 is confirmed by comparing the millimolar 
extinction coefficients versus wavelengths for uric acid (Vasilevsky, 2005). A higher value of 
the extinction coefficient corresponds to the higher correlation for RR of uric acid at 280 nm.  
The RR of urea is more related to RR at 280 nm both in serum and spent dialysate, but less 
so at 254 nm in serum (Fridolin, 2003). This means that relatively good correlation between 
the RR of UV absorbance and a particular solute may be achieved when the removal rate of 
a non-absorbing solute (e.g. urea) is similar to that of UV-absorbing substances during 
haemodialysis. This is also confirmed by very good correlation between several small 
molecular weight waste products and UV absorbance (Fridolin, 2002) and similar 
concentration changes during dialysis for several azotemic markers (e.g. urea, creatinine 
and uric acid) (Vanholder, 1992). The dominance of small molecular weight waste products 
among chromophores in serum and spent dialysate can be concluded because the number of 
detected HPLC peaks is not significantly different for serum filtered with a filter in cut-off 3 
kDa and 70 kDa. Furthermore, it seems that the UV-absorbing solutes can be subject to 
similar corrections regarding distribution volume and intercompartmental equilibration 
rates, similar to urea, although not with exactly the same distribution and equilibration 
intercompartmental rates in the body as urea. This makes it possible to estimate the 
delivered dialysis dose in terms of Kt/V by monitoring UV absorbance in spent dialysate 
online (Uhlin, 2003).  
The RR of creatinine demonstrates a high correlation for RR at 280 nm in both serum and 
spent dialysate. The reason could be similar removal of creatinine and other chromophores 
at 280 nm, where creatinine does not contribute significantly to UV absorbance (Figure 5).  
As previous studies have shown, and as is confirmed by this work, the HPLC is a method 
which has its own place for the detection of uremic solutes in biological solutes. This is an 
effective method of studying accumulated metabolites in patients’ blood and removed in 
dialysis. Identification of these metabolites gives us the opportunity to understand the 
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cumulative and integrated UV absorbance curve utilised during optical dialysis dose online 
monitoring. The online methods are felt to be more accurate than methods based on pre- 
and post-dialysis urea concentrations, and to be better suited to clinical routine. Continuous 
monitoring of uremic retention solute concentrations during a dialysis session could be 
beneficial for the prevention of intradialytic morbidity and for the confirmation of dialysis 
adequacy. 
7. Conclusions 
This chapter contributes new information about the removal of uremic retention solutes 
during hemodialysis and the origin of the optical dialysis adequacy monitoring signal. The 
relationship between characteristics of the online UV absorbance curve measured during 
dialysis and the identified HPLC peaks in spent dialysate was investigated.  It was 
demonstrated that the absorbance signal reflects the contribution of several UV-absorbing 
compounds in spent dialysate, with the strongest influence coming from the low-molecular-
weight water-soluble non-protein bound compounds. Moreover, UV absorbance behaves 
more like small water-soluble non-protein-bound solutes than small protein-bound solutes.  
Monitoring the removal of compounds with different properties and elimination 
characteristics during various dialysis strategies adds knowledge of dialysis treatment and 
would be useful for future research in order to decrease complications related to dialysis 
quality and cardiovascular risk factors. Hopefully the online methods will add a new 
technique and methodology to the wide discussion about the quality and adequacy of 
dialysis, uremic toxicity and kidney functionality. 
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